Surgical Sutures

Surgical Sutures

Global Surgical Sutures Market to Reach US$6.5 Billion by 2030

The global market for Surgical Sutures estimated at US$4.5 Billion in the year 2023, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Suture Thread, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in the Automated Suturing Device segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.7% CAGR

The Surgical Sutures market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Surgical Sutures Market - Key Trends and Drivers Summarized

Why Are Surgical Sutures Still Relevant in Modern Surgery?

Surgical sutures remain a fundamental tool in the medical field, providing an essential method for closing wounds, repairing tissues, and ensuring that post-surgical healing occurs without complications. Despite technological advancements like surgical staplers and glue, sutures continue to be the most preferred method, especially in delicate procedures such as cardiovascular surgeries and wound closure in plastic surgery. Their ability to offer precision in tissue approximation and reduce the risk of infection makes them indispensable across a wide range of surgical applications. Surgeons rely on sutures for their versatility in closing different types of tissues, making them essential for safe and effective surgery.

How Is Innovation in Sutures Improving Surgical Outcomes?

Technological advancements in surgical sutures are continually improving outcomes, particularly with the rise of absorbable and antibacterial sutures. Absorbable sutures dissolve within the body, eliminating the need for removal and reducing patient discomfort. Antibacterial sutures, on the other hand, are designed to reduce the risk of infection, an ongoing challenge in post-surgical recovery. Sutures have also seen improvements in strength and flexibility, ensuring better wound closure with minimal tissue reaction. The introduction of barbed sutures, which allow for knotless tissue approximation, is another significant development in this field, enhancing surgeon efficiency and reducing procedure time.

What Are the Key Segments Driving the Surgical Sutures Market?

The surgical sutures market is categorized into absorbable and non-absorbable sutures, with absorbable sutures dominating in surgeries where long-term tissue support is not required. The market is further divided based on material, including natural and synthetic sutures, with synthetic options such as polyglycolic acid seeing increasing demand due to their consistent performance. Hospitals remain the largest end-users of surgical sutures, although there is growing adoption in outpatient and ambulatory surgical centers. Geographically, North America leads the market, followed by Europe, while Asia-Pacific is expected to experience the fastest growth due to expanding healthcare infrastructure and rising surgical volumes.

What Is Driving Growth in the Surgical Sutures Market?

The growth in the surgical sutures market is driven by several factors, including the increasing number of surgeries globally, advancements in suture materials, and the rising demand for absorbable and antibacterial sutures. The growing number of minimally invasive surgeries, particularly in orthopedics and cosmetic surgery, is boosting demand for innovative suturing techniques. Moreover, the rising incidence of chronic diseases requiring surgery, coupled with the need to reduce postoperative complications, is further driving the market. Innovations in biocompatible materials, increasing focus on patient safety, and the rising number of outpatient surgeries are additional factors propelling market growth.

Select Competitors (Total 16 Featured) -

• Apollo Endosurgery, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• DemeTech Corp.
• EndoEvolution, LLC
• Ethicon US LLC
• Internacional FarmaceutiCA S.A. De C.V.
• Medtronic PLC
• Mellon Medical B.V.
• Peters Surgical
• Smith & Nephew PLC
• Surgical Specialties Corporation
• Sutures India Pvt., Ltd.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.